Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DYN
- Price
- 10.32
- Stock movement up
- +0.25 (2.09%)
- Company name
- Dyne Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.74B
- Ent value
- 1.27B
- Price/Sales
- 458.94
- Price/Book
- 2.46
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 53.36%
- 1 year return
- -73.50%
- 3 year return
- 0.75%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
DYN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 458.94 |
| Price to Book | 2.46 |
| EV to Sales | 335.17 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 142.26M |
| EPS (TTM) | -2.92 |
| FCF per share (TTM) | -2.42 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.79M |
| Gross profit (TTM) | 2.44M |
| Operating income (TTM) | -314.47M |
| Net income (TTM) | -294.51M |
| EPS (TTM) | -2.92 |
| EPS (1y forward) | -3.53 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 64.28% |
| Operating margin (TTM) | -8301.64% |
| Profit margin (TTM) | -7774.92% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 532.16M |
| Net receivables | 0.00 |
| Total current assets | 736.39M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 37.03M |
| Total assets | 768.84M |
| Accounts payable | 6.16M |
| Short/Current long term debt | 24.86M |
| Total current liabilities | 43.26M |
| Total liabilities | 63.30M |
| Shareholder's equity | 705.54M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -243.04M |
| Capital expenditures (TTM) | 1.38M |
| Free cash flow (TTM) | -244.42M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -41.74% |
| Return on Assets | -38.31% |
| Return on Invested Capital | -41.46% |
| Cash Return on Invested Capital | -34.41% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 11.84 |
| Daily high | 12.31 |
| Daily low | 11.64 |
| Daily Volume | 1.60M |
| All-time high | 47.04 |
| 1y analyst estimate | 35.35 |
| Beta | 1.08 |
| EPS (TTM) | -2.92 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 30 Oct 2025 |
Downside potential
Loading...
Downside potential data
| DYN | S&P500 | |
| Current price drop from All-time high | -74.02% | -1.46% |
| Highest price drop | -85.52% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -48.66% | -10.99% |
| Avg time to new high | 62 days | 12 days |
| Max time to new high | 839 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.74B
Marketcap category
Small-cap
Description
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Employees
206
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page